TICKERNERD
Menu
CLVTCLVTTechnology · Information Technology Services

CLVT Stock Forecast: Clarivate Plc Price Predictions for 2026-2027

Last close, 8 Oct 2026
$1.63
+10.88% on the day

The 8 Wall Street analysts covering Clarivate Plc hold a median 12-month price target of $2.55 — +56.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 67 of 100 as at 8 Oct 2026 — in the upper half.

Market cap
$940.3M
Ticker Nerd rank
67 / 100
Median analyst target
$2.55
Analysts covering
8
Revenue$587.3M−5.5% y/y
Operating income$36.0M
Net income−$268.6M
Free cash flow$44.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.9%
1M
−14.2%
YTD
−51.2%
1Y
−56.3%
From 52W high
−56.6%
From 52W low
+12.4%
$1.45
$3.76
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CLVT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Clarivate Plc on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Oct 2026
67 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
98
Accruals
91
Value
87
Revisions
58
Quality
51
Growth
44
Size
43
Volatility
26
Momentum
11

Issuance (98): The share count has been shrinking and the company is not leaning on new borrowing.

Momentum (11): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CLVT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CLVT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$2.00$3.00$4.00$5.00$6.00Jan 26Apr 26Jul 26Oct 26CLVTHigh $5.50Median $2.55Low $2.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says8 analysts
2 Buy5 Hold1 Sell
Low $2.00Median $2.55High $5.50

The green dot is the last close — the median target sits +56.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 4 moved it down.

DateFirmActionRatingTarget
30 July 2026BarclaysMaintainsUnderweight$2.50 → $2.00
30 July 2026CitigroupMaintainsNeutral$2.80 → $2.50
30 July 2026Goldman SachsMaintainsNeutral$2.90 → $2.60
30 July 2026StifelMaintainsBuy$6.00 → $5.00
7 July 2026BarclaysMaintainsUnderweight—
7 July 2026BarclaysMaintainsUnderweight$2.40 → $2.50
4 Mar 2026CitigroupMaintainsNeutral—
25 Feb 2026BarclaysMaintainsUnderweight—
25 Feb 2026RBC CapitalMaintainsSector Perform—
8 Jan 2026Goldman SachsDowngradeNeutral—
17 Dec 2025Morgan StanleyDowngradeUnderweight—
3 Sept 2025Wolfe ResearchInitiatesPeer Perform—
18 July 2025JefferiesDowngradeHold—
20 Feb 2025RBC CapitalReiteratesSector Perform—
7 Nov 2024BarclaysMaintainsUnderweight—
7 Nov 2024RBC CapitalMaintainsSector Perform—
6 Nov 2024William BlairDowngradeMarket Perform—
7 Aug 2024BarclaysMaintainsUnderweight—
7 Aug 2024RBC CapitalMaintainsSector Perform—
9 May 2024Goldman SachsMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CLVT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CLVT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 8 Oct 2026, Clarivate Plc returned −56.3% against +16.2% for the S&P 500, dividends included.

CLVT vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26CLVTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CLVT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.4%
Analysts raising
2
Analysts cutting
1
Fundamentals

Clarivate Plc (CLVT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
30.8×

Cheaper than 25% of US stocks

Price / sales
0.4×

Cheaper than 85% of US stocks

Price / book
0.2×

Cheaper than 89% of US stocks

EV / EBITDA
5.5×

Cheaper than 52% of US stocks

Growth & margins
Revenue growth (YoY)
−5.5%

Higher than 19% of US stocks

Earnings growth (YoY)
−5.5%

Higher than 30% of US stocks

Gross margin
68.4%

Higher than 81% of US stocks

Operating margin
6.1%

Higher than 57% of US stocks

Net margin
−13.8%

Higher than 18% of US stocks

Returns & dividend
Return on equity
−7.0%

Higher than 38% of US stocks

Return on assets
0.9%

Higher than 49% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Clarivate Plc (CLVT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Clarivate Plc has a market value of $940.3M and an enterprise value of $5.0B.

  • Revenue in the twelve months to 30 June 2026: $2.4B. The latest quarter shrank 5.5% year on year.

  • Net income over the same four quarters: −$334.0M, a −13.8% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.52.

  • Free cash flow in the twelve months to 30 June 2026: $327.6M, after $246.8M of capital spending.

  • Clarivate Plc spent $143.1M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 639.7M.

  • Trailing P/E: 30.8×; forward P/E: 2.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Clarivate Plc employs 12,000 people — $201K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 8 Oct 2026

Data provided by Twelve Data

Peers

CLVT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelInformation Technology Services
CompanyMarket capTKN rank
CLVTClarivate Plc$940.3M
67
VYXNCR Voyix Corp.$950.9M
81
BBAIBigBear.ai Holdings, Inc.$1.2B
13
NABLN-able, Inc.$847.7M
42
SHAZSharonAI Holdings, Inc.$1.4B
2
MGRTMega Fortune Co., Ltd.$1.4B
9
EFOREverforth, Inc.$1.5B
66

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Clarivate Plc — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CLVT news & analysis

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

PRNewsWire · 6 Oct 2026positive

Clarivate completed the sale of its Life Sciences & Healthcare segment to Altaris for $600 million. The transaction, announced July 6, 2026, advances the company’s transformation and simplifies its portfolio.

Why it matters — The sale sharpens Clarivate’s focus on its Academia & Government and Intellectual Property segments, while proceeds strengthen its balance sheet and financial flexibility.

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

PRNewsWire · 24 Sept 2026neutral

Clarivate Plc announced the expiration and final results of its cash tender offer, conducted by its wholly-owned subsidiary Clarivate Science Holdings Corporation, to purchase up to $75,000,000 aggregate principal amount of its outstanding 3.875% Senior Secured Notes due 2028, pursuant to the Offer to Purchase dated September 17, 2026.

Why it matters — A CLVT watcher would care because the completion of this cash tender offer reflects the company's ongoing debt-management activity and use of cash toward its outstanding senior secured notes.

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

PRNewsWire · 23 Sept 2026neutral

Clarivate Plc announced the pricing terms, including the Reference Yield and Total Consideration, for its previously announced cash tender offer by its subsidiary Clarivate Science Holdings Corporation to purchase certain of its outstanding debt securities. The terms are set forth in the Offer to Purchase dated September 17, 2026.

Why it matters — CLVT watchers would care because this sets the specific pricing terms for the company's debt-management transaction, which affects its capital structure and outstanding notes.

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

PRNewsWire · 22 Sept 2026neutral

Clarivate Plc announced it will report its third quarter 2026 financial results before the market opens on Tuesday, November 3, 2026. The announcement was made on September 22, 2026, via PR Newswire.

Why it matters — CLVT watchers will note the scheduled date for the company's third quarter earnings disclosure, which provides a timeline for assessing its latest financial performance.

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

PRNewsWire · 17 Sept 2026neutral

Clarivate Plc announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation, has commenced a cash tender offer to purchase certain of its outstanding debt securities, with terms and conditions set out in an Offer to Purchase dated September 17, 2026.

Why it matters — A cash tender offer for outstanding notes is a notable capital structure action that could affect Clarivate's debt profile and financial standing.

FAQ

Frequently asked questions about CLVT stock

What is the CLVT stock price forecast for 2026-2027?

The 8 Wall Street analysts covering Clarivate Plc have a median 12-month price target of $2.55, with estimates ranging from $2 to $5.5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CLVT stock a buy right now?

Of the 8 analysts covering Clarivate Plc, 2 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Clarivate Plc 67 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CLVT?

As at 8 Oct 2026, Clarivate Plc ranks 67 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (98 of 100).

Will CLVT stock go up?

No one can know that. What the data says: the median 12-month target from 8 analysts implies +56.4% from the last close, and Ticker Nerd's factor model ranks Clarivate Plc 67 out of 100 as at 8 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CLVT stock forecast for 2030?

No analyst covering Clarivate Plc publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLVT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2 to $5.5 over the next 12 months.

How has CLVT stock performed over the past year?

Clarivate Plc returned -56.3% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Clarivate Plc do?

Clarivate Plc is a global information, analytics, and workflow solutions company focused on academia and government, intellectual property, and life sciences and healthcare. Clarivate provides subscription-based tools and expert services that support research discovery, scholarly publishing, citation analysis, patent intelligence, trademark protection, and regulatory and safety workflows.

What is the latest news on CLVT?

The most recent item we track (PRNewsWire, 6 Oct 2026): "Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation". Clarivate completed the sale of its Life Sciences & Healthcare segment to Altaris for $600 million. The transaction, announced July 6, 2026, advances the company’s transformation and simplifies its portfolio.

Company

About Clarivate Plc.

Clarivate Plc is a global information, analytics, and workflow solutions company focused on academia and government, intellectual property, and life sciences and healthcare. Clarivate provides subscription-based tools and expert services that support research discovery, scholarly publishing, citation analysis, patent intelligence, trademark protection, and regulatory and safety workflows. Its product portfolio includes widely used platforms for academic research, library management, patent analytics, brand protection, and life sciences intelligence, helping organizations manage data, monitor innovation, and streamline critical processes. Clarivate serves universities, research institutions, corporations, law firms, government agencies, and healthcare and pharmaceutical organizations across global markets. Headquartered in London, Clarivate is an important provider of specialized intelligence and software used by professionals who rely on trusted information to make decisions and manage complex knowledge-intensive operations.

CEO Mr. Matitiahu Shem Tov · 12,000 employees · United Kingdom · https://www.clarivate.com